SEC Company Response from Lifevantage Corp (LFVN) (CIK 0000849146) (LFVN) — Mar 22, 2006

Lifevantage Corp (LFVN) (CIK 0000849146)
Date: March 22, 2006 · CIK: 0000849146 · Accession: 0001035704-06-000208

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-126288

Date

March 17, 2006

Author

/s/ Jon S. Ploetz

Form

CORRESP

Company

Lifevantage Corp (LFVN) (CIK 0000849146)

Letter

Securities And Exchange Commission Registration Statement on Form SB-2 File No. 333-126288 Amended February 3, 2006 Form 10-QSB for the Fiscal Quarter Ended March 31, 2005

Dear Mr. Slivka,

As we discussed, Lifeline Therapeutics, Inc. (the “Company”) is currently reviewing the comments on the Company’s periodic reports in the March 6, 2006 letter from Assistant Director Long (the “Comments”). The Company has requested that we inform you that they are working on responses to the Comments with their accountants, however are not able at this point to confirm when they will be able to respond to the Comments. The Company expects to have a timeframe for a response to the Comments next week and we will update you accordingly next week.

Regards,
/s/ Jon S. Ploetz

Show Raw Text

CORRESP
1
filename1.htm

corresp

[Patton Boggs LLP Letterhead]

March 17, 2006

    Via facsimile: (202) 772-9368

    Jon S. Ploetz

    Mr. Craig Slivka

    303-894-6111

    Staff Attorney

    jploetz@pattonboggs.com

    Securities And Exchange Commission

    100 F Street, NE

    Mail Stop 7010

    Washington, D.C. 20549

    Re:

    Lifeline Therapeutics, Inc.

    Registration Statement on Form SB-2

    File No. 333-126288

    Amended February 3, 2006

    Form 10-QSB for the Fiscal Quarter Ended March 31, 2005

Dear Mr. Slivka,

     As we discussed, Lifeline Therapeutics, Inc. (the “Company”) is currently reviewing the
comments on the Company’s periodic reports in the March 6, 2006 letter from Assistant Director Long
(the “Comments”). The Company has requested that we inform you that they are working on responses
to the Comments with their accountants, however are not able at this point to confirm when they
will be able to respond to the Comments. The Company expects to have a timeframe for a response to
the Comments next week and we will update you accordingly next week.

    Regards,

    /s/ Jon S. Ploetz

    Jon S. Ploetz

    cc:

    Mr. Gerald Houston

    Lifeline Therapeutics, Inc.

SecProbe.io